16+
Major trials tracked
Cardiometabolic & renal · Live ClinicalTrials.gov data
Empagliflozin (Jardiance) clinical trial pipeline
The timeline below tracks the 16 largest phase 2–4 empagliflozin trials on ClinicalTrials.gov by enrolment, 5 of them actively recruiting. The next phase 3 primary completion among them is expected Aug 2026. Refreshed daily — add up to four competitors to compare pipelines side by side.
7
Phase 3 trials
5
Actively recruiting
Aug 2026
Next phase 3 primary completion
82,277
Participants across trials
Boehringer Ingelheim
Lead sponsor by trial count
empagliflozin (16)10 active2009–2032
empagliflozin
'09
'11
'13
'15
'17
'19
'21
'23
'25
'27
'29
'31
empagliflozin
Empagliflozin (BI 10773) in Type Two Diabetes (T2D) Patients, Open Label ExtensionP2
Efficacy and Safety of Empagliflozin (BI 10773) Versus Placebo and Sitagliptin Over 24 Weeks in Patients With Type 2 DiabetesP3
ERA-HFP4
EMPA post-GDMP3
RECOVERYP3
Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes MellitusP4
EMPACT-MI: A Study to Test Whether Empagliflozin Can Lower the Risk of Heart Failure and Death in People Who Had a Heart Attack (Myocardial Infarction)P3
Use of SGLT2i in noHCM With HFpEFP4
EMPA-AHFP3
The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Body Weight in Type 2 Diabetic Patients .P4
SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes MellitusP4
Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in BangladeshP4
Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 DiabetesP4
SLGT2i for Neuroprotection in Patients With Acute Ischemic StrokeP3
A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients With Type 2 Diabetes Mellitus and High Body Mass Index (BMI)P4
EMPASTONEP3
Upcoming readouts
7 ahead · empagliflozin
Select a trial to load its full ClinicalTrials.gov record.
Key empagliflozin trials
Top 12 of the 16 tracked phase 2–4 trials, ordered by phase and status. Each links to its full ClinicalTrials.gov record.
| Trial | Title | Phase | Status | Primary completion |
|---|---|---|---|---|
| NCT06989723 | Pioglitazone and Empagliflozin for Fatty Liver Disease in Type 2 Diabetes | Phase 4 | Recruiting | Dec 2026 |
| NCT06364930 | SGLT2i to Prevent of Liver Complications in Patients With CHB and Diabetes Mellitus | Phase 4 | Recruiting | Oct 2030 |
| NCT06449235 | Real-World Evaluation of Omarigliptin for Type 2 Diabetes Meliitus in Bangladesh | Phase 4 | Not yet recruiting | Apr 2025 |
| NCT07311551 | A Comparison of Effectiveness, Safety, and Cost-effectiveness of Dapagliflozin and Empagliflozin in Patients W… | Phase 4 | Not yet recruiting | Dec 2026 |
| NCT05359432 | Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus | Phase 4 | Completed | Aug 2021 |
| NCT07247656 | The Efficacy and Safety of Empagliflozin - Linagliptin and Empagliflozin- Metformin Therapy in Reduction of Bo… | Phase 4 | Completed | Mar 2023 |
| NCT03271879 | ERA-HF — Empagliflozin Versus Placebo on the Rate of Arrhythmic Events in Heart Failure Patients | Phase 4 | Unknown | Sept 2019 |
| NCT06401343 | Use of SGLT2i in noHCM With HFpEF | Phase 4 | Unknown | Aug 2024 |
| NCT05392764 | EMPA-AHF — Early Treatment With a Sodium-glucose Co-transporter 2 Inhibitor in High-risk Patients With Acute Heart Failur… | Phase 3 | Recruiting | Dec 2026 |
| NCT04381936 | RECOVERY — Randomised Evaluation of COVID-19 Therapy | Phase 3 | Recruiting | Sept 2028 |
| NCT06653738 | EMPASTONE — Trial to Assess the Efficacy of EMPAgliflozin and Personalized Dietary Counseling for Kidney STONE Prevention | Phase 3 | Recruiting | Sept 2030 |
| NCT07105917 | SLGT2i for Neuroprotection in Patients With Acute Ischemic Stroke | Phase 3 | Not yet recruiting | Aug 2026 |
Related drug pipelines
FAQ
- How many clinical trials are running for empagliflozin?
- ClinicalTrials.gov lists more than 16 phase 2–4 empagliflozin trials. This page tracks the 16 largest by enrolment: 1 phase 2, 7 phase 3, and 8 phase 4 among them, with 5 actively recruiting. Updated daily.
- Where does this data come from?
- All trial data is sourced from ClinicalTrials.gov (CTGov) and refreshed on this page daily.
- Can I compare empagliflozin against other drugs?
- Yes. The free ComplyRx Trial Pipeline tool compares up to five drugs side by side on one timeline, with PNG and PDF export. Add any competitor in the search box above.
Join the waitlist
Be the first to access ComplyRx
We'll let you know as soon as your spot opens to use ComplyRx.
By joining, you agree to our Privacy Policy.